首页 | 本学科首页   官方微博 | 高级检索  
检索        


Pleural “drop metastases” 21 years after resection of a thymoma
Authors:Chia‐Chun Chiang MD  Angela M Parsons DO  J Scott Kriegshauser MD  Harshita R Paripati MD  Matthew A Zarka MD  A Arturo Leis MD
Institution:1. Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA;2. Department of Radiology, Mayo Clinic, Phoenix, Arizona, USA;3. Department of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona, USA;4. Department of Pathology, Mayo Clinic, Scottsdale, Arizona, USA;5. Center for Neuroscience and Neurological Recovery, Methodist Rehabilitation Center, Jackson, Mississippi, USA
Abstract:Introduction: We describe an unusual case of pleural drop metastases 21 years after complete resection of an encapsulated thymoma in a Southeast Asian patient with myasthenia gravis (MG). Methods: This investigation includes a case report and brief review of the literature. Results: The patient presented in 2015 with generalized weakness, fatigue, and shortness of breath, but no diplopia, ptosis, dysphagia, or dysarthria. Because these symptoms were atypical for an MG exacerbation, a de‐novo work‐up was performed. Chest computed tomography (CT) showed numerous pleural nodules (“drop metastases”), and CT‐guided biopsy revealed metastatic thymoma. Conclusions: The average disease‐free interval for thymoma ranges from 68 to 86 months. Pleural and mediastinal recurrence are more common than distant hematogenous recurrence. Adverse prognostic factors include an initial higher Masaoka stage, incomplete resection, older age, and pleural or pericardial involvement. Despite apparent complete resection of thymoma, clinicians should remain vigilant for recurrence for as long as 20 years after initial management. Long‐term follow‐up with radiologic surveillance is recommended. Muscle Nerve 56 : 171–175, 2017
Keywords:disease‐free survival  disease surveillance  drop metastases  myasthenia gravis  recurrence  thymoma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号